Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ringe

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Transplantation|March 22, 2001
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetilB Ringe, F Braun, E Schütz, et al.
Transplantation Proceedings|October 1, 1991
Arterial blood ketone body ratio as an indicator for viability of donor liversN Ozaki, G Gubernatis, B Ringe, et al.
Transplantation Proceedings|February 1, 1989
Liver grafting for malignant liver tumorsR Pichlymayr, B Ringe, C Wittekind, et al.
Transplantation Proceedings|June 24, 1998
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipientsF Braun, T Lorf, C Grupp, et al.
Der Internist|February 12, 1998
[Surgical therapy of benign liver tumors]B Ringe, R Canelo, T Lorf, et al.
Transplantation Proceedings|March 31, 2004
Kinetics and localization of interleukin-2, interleukin-6, heat shock protein 70, and interferon gamma during intestinal-rerfusion injuryF Braun, M Hosseini, E Wieland, et al.
Zentralblatt Fur Chirurgie|April 29, 1998
[Diagnostic and therapeutic strategies in hepatocellular adenoma]A Weimann, K Fronhoff, K F Gratz, et al.
European Journal of Clinical Investigation|July 1, 1995
Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant periodV W Armstrong, E Schütz, M Kaltefleiter, et al.
The Japanese Journal of Surgery|November 1, 1985
Developments in liver transplantationR Pichlmayr, P Neuhaus, B Ringe, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Refractory hydrothorax in primary biliary cirrhosis: successful treatment with transjugular intrahepatic portosystemic stent shunt]W Nolte, H R Figulla, B Ringe, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Transplantation|March 22, 2001
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetilB Ringe, F Braun, E Schütz, et al.
Transplantation Proceedings|October 1, 1991
Arterial blood ketone body ratio as an indicator for viability of donor liversN Ozaki, G Gubernatis, B Ringe, et al.
Transplantation Proceedings|February 1, 1989
Liver grafting for malignant liver tumorsR Pichlymayr, B Ringe, C Wittekind, et al.
Transplantation Proceedings|June 24, 1998
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipientsF Braun, T Lorf, C Grupp, et al.
Der Internist|February 12, 1998
[Surgical therapy of benign liver tumors]B Ringe, R Canelo, T Lorf, et al.
Transplantation Proceedings|March 31, 2004
Kinetics and localization of interleukin-2, interleukin-6, heat shock protein 70, and interferon gamma during intestinal-rerfusion injuryF Braun, M Hosseini, E Wieland, et al.
Zentralblatt Fur Chirurgie|April 29, 1998
[Diagnostic and therapeutic strategies in hepatocellular adenoma]A Weimann, K Fronhoff, K F Gratz, et al.
European Journal of Clinical Investigation|July 1, 1995
Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant periodV W Armstrong, E Schütz, M Kaltefleiter, et al.
The Japanese Journal of Surgery|November 1, 1985
Developments in liver transplantationR Pichlmayr, P Neuhaus, B Ringe, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Refractory hydrothorax in primary biliary cirrhosis: successful treatment with transjugular intrahepatic portosystemic stent shunt]W Nolte, H R Figulla, B Ringe, et al.
Pageof 29